Summary Summary Psychiatric disorders have
Psychiatric disorders have been associated with poor outcome in been associated with poor outcome in individuals with chronic fatigue syndrome individuals with chronic fatigue syndrome (CFS).This study examines the impact of (CFS).This study examines the impact of psychiatric disorders on outcome of psychiatric disorders on outcome of cognitive^behavioural therapy (CBT). cognitive^behavioural therapy (CBT). Psychiatric diagnoses were assessed with a Psychiatric diagnoses were assessed with a structured psychiatric interview in a CBT structured psychiatric interview in a CBT trial of 270 people with CFS.Lifetime and trial of 270 people with CFS.Lifetime and current psychiatric disorders were found current psychiatric disorders were found in 50 and 32% respectively.No significant in 50 and 32% respectively.No significant differences in fatigue severity and differences in fatigue severity and functionalimpairment following treatment functionalimpairment following treatment were found between participants with were found between participants with and without psychiatric diagnoses. and without psychiatric diagnoses.
Declaration of interest
Declaration of interest None.
None. Funding detailed in Acknowledgement. Funding detailed in Acknowledgement.
The prevalence of psychiatric disorders in The prevalence of psychiatric disorders in chronic fatigue syndrome (CFS) has been chronic fatigue syndrome (CFS) has been obscured by varying CFS criteria, instruobscured by varying CFS criteria, instruments and research settings and by sympments and research settings and by symptom overlap (Wessely tom overlap (Wessely et al et al, 1998) . Studies , 1998) . Studies of psychiatric disorders as predictors of of psychiatric disorders as predictors of CFS prognosis have produced conflicting CFS prognosis have produced conflicting results (Wessely results (Wessely et al et al, 1998 (Wessely et al et al, ), raising , 1998 , raising questions about the impact of psychiatric questions about the impact of psychiatric comorbidity on the outcome of cognitivecomorbidity on the outcome of cognitivebehavioural therapy (CBT), an effective behavioural therapy (CBT), an effective therapy for CFS (Whiting therapy for CFS (Whiting et al et al, 2001) . , 2001). When psychiatric diagnoses were assessed When psychiatric diagnoses were assessed in CBT trials, their effect on treatment outin CBT trials, their effect on treatment outcome was not reported (Sharpe come was not reported (Sharpe et al et al, 1996) , , 1996), significant differences in improvement were significant differences in improvement were not found (Deale not found (Deale et al et al, 1997) and poor out-, 1997) and poor outcome was associated with psychiatric come was associated with psychiatric history (Bonner history (Bonner et al et al, 1994) . In our CBT , 1994). In our CBT trial, psychiatric comorbidity might have trial, psychiatric comorbidity might have caused moderate clinically significant caused moderate clinically significant improvement and a high rate of withdrawal improvement and a high rate of withdrawal from the trial (Prins from the trial (Prins et al et al, 2001) . In this , 2001). In this study, psychiatric diagnoses in CFS patients study, psychiatric diagnoses in CFS patients will be examined in relation to treatment will be examined in relation to treatment outcome. outcome.
METHOD METHOD
Sample and procedure Sample and procedure Psychiatric disorders were studied in 270 Psychiatric disorders were studied in 270 individuals with CFS in a randomised conindividuals with CFS in a randomised controlled CBT trial (full details: Prins trolled CBT trial (full details: Prins et al et al, , 2001 ). Anxiety disorders, mood disorders, 2001). Anxiety disorders, mood disorders, somatoform disorders and post-traumatic somatoform disorders and post-traumatic stress disorder were assessed at baseline stress disorder were assessed at baseline using the Structured Clinical Interview for using the Structured Clinical Interview for DSM-III-R (SCID-III-R; Spitzer DSM-III-R (SCID-III-R; Spitzer et al et al, , 1990 
Statistical analysis Statistical analysis
Lifetime prevalence refers to disorders at Lifetime prevalence refers to disorders at some time in a participant's life and current some time in a participant's life and current prevalence refers to disorders at the time of prevalence refers to disorders at the time of the study. Controlling for overlap between the study. Controlling for overlap between depression and CFS, mood disorders depression and CFS, mood disorders were calculated both with and without were calculated both with and without fatigue and/or poor concentration. We used fatigue and/or poor concentration. We used Z Z-scores to compare percentages of -scores to compare percentages of psychiatric disorders in the trial participsychiatric disorders in the trial participants and in the general population. Perpants and in the general population. Percentages of participants with and without centages of participants with and without psychiatric disorders in those completing psychiatric disorders in those completing and not completing the trial were compared and not completing the trial were compared using Fisher's exact test. Main and interusing Fisher's exact test. Main and interaction effects of psychiatric diagnoses on action effects of psychiatric diagnoses on the outcome variables were analysed with the outcome variables were analysed with a general linear model for repeated meaa general linear model for repeated measurements, with trial condition, current surements, with trial condition, current psychiatric diagnosis and their first-order psychiatric diagnosis and their first-order interactions as independent variables. interactions as independent variables.
RESULTS RESULTS

Prevalence of psychiatric disorders Prevalence of psychiatric disorders
The data of 264 participants were analysed The data of 264 participants were analysed (6 were omitted, owing to missing data). (6 were omitted, owing to missing data). Table 1 shows that lifetime psychiatric dis- Table 1 shows that lifetime psychiatric disorders were present in 50% of participants orders were present in 50% of participants and that 28% had two or more diagnoses. and that 28% had two or more diagnoses. Current psychiatric disorders were reported Current psychiatric disorders were reported by 32.2%, 11% of whom had two or more by 32.2%, 11% of whom had two or more diagnoses. Lifetime and current mood disdiagnoses. Lifetime and current mood disorders were found in 37.1 and 18.9% orders were found in 37.1 and 18.9% respectively, and lifetime and current anxirespectively, and lifetime and current anxiety disorders in 19.7 and 13.3% respecety disorders in 19.7 and 13.3% respectively. Only two participants (0.9%) had tively. Only two participants (0.9%) had post-traumatic stress disorder in remission. post-traumatic stress disorder in remission. Other current somatoform disorders were Other current somatoform disorders were identified in 8.3%, and 4.9% had a lifetime identified in 8.3%, and 4.9% had a lifetime somatisation disorder. somatisation disorder.
Participants with lifetime or current Participants with lifetime or current psychiatric disorders were not significantly psychiatric disorders were not significantly different from those without in terms of different from those without in terms of age, duration of complaints, education, age, duration of complaints, education, fatigue and functional impairment. Gender fatigue and functional impairment. Gender differences were found in lifetime differences were found in lifetime psychiatric diagnoses ( . No significant differences were found between particidifferences were found between participants with and without lifetime or current pants with and without lifetime or current psychiatric diagnoses in the groups of those psychiatric diagnoses in the groups of those who completed or did not complete the who completed or did not complete the trial. After controlling for CFS symptoms, trial. After controlling for CFS symptoms, fatigue and poor concentration, we found fatigue and poor concentration, we found lifetime and current mood disorders in lifetime and current mood disorders in 26.5 and 14% of participants respectively, 26.5 and 14% of participants respectively, and lifetime and current psychiatric and lifetime and current psychiatric disorders in 42.8 and 28.4% respectively. disorders in 42.8 and 28.4% respectively.
Psychiatric disorders Psychiatric disorders and treatment outcome and treatment outcome
In the outcome variables fatigue severity In the outcome variables fatigue severity and functional impairment, neither main and functional impairment, neither main 1 8 4 1 8 4 . This indicated that participants with a current psychiatric diagnosis had with a current psychiatric diagnosis had higher BDI and SCL-90 scores at baseline, higher BDI and SCL-90 scores at baseline, 8 and 14 months, compared with patients 8 and 14 months, compared with patients without a current psychiatric diagnosis, without a current psychiatric diagnosis, but both groups had similar difference scores but both groups had similar difference scores from baseline to post-test and follow-up. from baseline to post-test and follow-up.
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S H O R T R E P O R T S H O R T R E P O R T Effect of psychiatric disorders on outcome
DISCUSSION DISCUSSION
The prevalence of psychiatric diagnoses in The prevalence of psychiatric diagnoses in our sample of individuals with CFS seems our sample of individuals with CFS seems low to moderate compared with DSM-IIIlow to moderate compared with DSM-III-R diagnoses found in other studies (Wessely R diagnoses found in other studies (Wessely et al et al, 1998) . As in other studies, post-, 1998). As in other studies, posttraumatic stress disorder was rare. In contraumatic stress disorder was rare. In contrast to most studies, in which between 10 trast to most studies, in which between 10 and 20% fulfil the criteria, less than 5% and 20% fulfil the criteria, less than 5% of our participants screened positive for of our participants screened positive for somatisation disorder. Lower prevalence somatisation disorder. Lower prevalence rates may be the result of the research rates may be the result of the research setting, in which patients with a main comsetting, in which patients with a main complaint of fatigue were referred to an internal plaint of fatigue were referred to an internal medicine out-patient clinic. The specialist medicine out-patient clinic. The specialist might have diagnosed CFS instead of a might have diagnosed CFS instead of a psychiatric disorder or psychiatric symppsychiatric disorder or psychiatric symptoms might have been interpreted as a nortoms might have been interpreted as a normal reaction to physical illness. Examiners mal reaction to physical illness. Examiners were not biased to diagnose somatisation were not biased to diagnose somatisation disorder or other psychiatric disorders in disorder or other psychiatric disorders in the trial participants. Somatic complaints the trial participants. Somatic complaints rather than psychiatric symptoms were rather than psychiatric symptoms were our primary interest. our primary interest.
The question arises whether overdiagThe question arises whether overdiagnosis explains the higher percentages of nosis explains the higher percentages of mood disorders in people with CFS than mood disorders in people with CFS than in the general population. Controlling for in the general population. Controlling for CFS symptoms, respectively 9 and 5% CFS symptoms, respectively 9 and 5% fewer mood disorders resulted. Since more fewer mood disorders resulted. Since more CFS patients were female, a gender effect CFS patients were female, a gender effect might also explain the differences. might also explain the differences.
In contrast to what we expected, equal
In contrast to what we expected, equal treatment effects of CBT were found for treatment effects of CBT were found for participants with and without current psyparticipants with and without current psychiatric disorders. Depression and psychochiatric disorders. Depression and psychological distress also benefited from CBT logical distress also benefited from CBT specially tailored for CFS. Treating psychispecially tailored for CFS. Treating psychiatric comorbidity may relieve psychological atric comorbidity may relieve psychological distress, but does not alter fatigue severity. distress, but does not alter fatigue severity. Another interesting finding concerned the Another interesting finding concerned the natural course of CFS, which was not natural course of CFS, which was not adversely affected by current psychiatric adversely affected by current psychiatric comorbidity over 14 months. This concomorbidity over 14 months. This confirmed results of an earlier study, in which firmed results of an earlier study, in which depression was not a significant factor in depression was not a significant factor in the persistence of CFS (Vercoulen the persistence of CFS (Vercoulen et al et al, , 1998) . 1998). 
